IL1B and Insulin resistance: In this regard, the inhibition of NF-κB activation explains the reduced serum levels of TNF-α, IL-1β, and IL-6 in diacerhein-treated animals and, consequently, the improvement in the sepsis-induced insulin-resistance process.